netupitant palonosetron Akynzeo
Selected indexed studies
- Netupitant/palonosetron (Akynzeo) for chemotherapy-induced nausea and vomiting. (Med Lett Drugs Ther, 2015) [PMID:25897549]
- ** (, 2018) [PMID:30457774]
- Antiemetics: ASCO Guideline Update. (J Clin Oncol, 2020) [PMID:32658626]
_Worker-drafted node — pending editorial review._
Connections
netupitant palonosetron Akynzeo is a side effect of
Sources
- Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting. (2021) pubmed
- Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice. (2022) pubmed
- Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting. (2015) pubmed
- Netupitant/palonosetron (Akynzeo) for chemotherapy-induced nausea and vomiting. (2015) pubmed
- PMID:30457774 (2018) pubmed
- Netupitant/Palonosetron. (2015) pubmed
- Antiemetics: ASCO Guideline Update. (2020) pubmed
- Palonosetron. (2006) pubmed
- PMID:30475551 (2018) pubmed
- The role of netupitant and palonosetron in chemotherapy-induced nausea and vomiting. (2016) pubmed